Virus News and Research

Latest Virus News and Research

Survey demonstrates financial and mental health damage that may outlive the COVID threat

New Yorkers entering their third year of COVID have bleak views of the near-term economy and a strong conviction that vaccines should be required for those seeking to participate in their city's indoor activities (69%), to work in its service industries (66%) or schools (69%), and even to travel on airplanes (68%).

11 Feb 2022

Novel molecule shows ability to inhibit the replication of all coronaviruses

Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into a drug suitable for treating COVID-19.

10 Feb 2022

Case study: COVID-19 preventive behaviors impacted by implicit social pressure, desire for normalcy

As we move into the third year of the COVID-pandemic, we still face a multitude of information and it can be hard to know what guidelines to follow.

10 Feb 2022

Unavailability of COVID-19 testing linked to greater intentions to engage in risky behavior

A research survey of more than 1,100 people in the United States found that when COVID-19 testing wasn't available in their community, participants showed significantly greater intentions to engage in risky behavior, possibly leading to increased transmission of the virus.

10 Feb 2022

Study identifies SARS-CoV-2 variants with potential to escape the immune system's T cell response

A number of existing strains of SARS-CoV-2, as well as other future variants that could arise, have the potential to escape the immune system's cytotoxic T cell response in some portion of the population.

10 Feb 2022

ISU surveillance efforts uncover invasive mosquito species in three Iowa counties

Iowans might notice some new uninvited guests crashing their summer barbecues this year.

10 Feb 2022

KHN’s ‘What the Health?’: FDA takes center stage

The FDA is still lacking a Senate-confirmed leader, but the agency is at the center of several major policy battles. Lawmakers this year must renew the bill that authorizes drug companies to pay "user fees," which enable the agency to hire additional reviewers to speed the approval of drugs.

10 Feb 2022

Spillover of SARS-CoV-2 Omicron variant infection in white-tailed deer in New York

Researchers detected evidence for SARS-CoV-2 Omicron variant exposure in the white-tailed deer population inhabiting Staten Island in New York.

10 Feb 2022

Study reports accumulation of SARS-CoV-2 RNA in sewer biofilms

During the COVID-19 pandemic, monitoring the levels of SARS-CoV-2 RNA in wastewater entering treatment plants has been one way that researchers have gauged the disease's spread.

10 Feb 2022

Study: Almost a third of older adults infected with covid-19 develop new conditions

Almost a third (32 of every 100) of older adults infected with covid-19 in 2020 developed at least one new condition that required medical attention in the months after initial infection, 11 more than those who did not have covid-19, finds a US study published by The BMJ today.

10 Feb 2022

Scientists identify multi-kinase inhibitors that can effectively block SARS-CoV-2-mediated cytokine release

Researchers investigated the efficacy of two multi-kinase inhibitors, olverembatinib and ponatinib, in inhibiting SARS-CoV-2 omicron-mediated cytokine release in human peripheral blood mononuclear cells.

10 Feb 2022

Protective efficacy of BNT162b2 and Ad26.COV2.S against SARS-CoV-2 Omicron challenge in nonhuman primates

The study highlights the significance of mix-and-match vaccine regimens to diversify the immune responses against highly mutated variants of SARS-CoV-2 such as Omicron.

10 Feb 2022

Comparison of SARS-CoV-2 test performance by sample type and modality in close contacts of SARS-CoV-2 cases

In this study, researchers looked at how well molecular and antigen testing performed in symptomatic and asymptomatic close contacts of SARS-CoV-2 positive people.

10 Feb 2022

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

In two recent studies, researchers at Washington University School of Medicine in St. Louis found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants — at least in rodents — but that many antibody-based therapies may not be effective against it.

10 Feb 2022

Virus News and Research

Latest Virus News and Research

Survey demonstrates financial and mental health damage that may outlive the COVID threat

Novel molecule shows ability to inhibit the replication of all coronaviruses

Case study: COVID-19 preventive behaviors impacted by implicit social pressure, desire for normalcy

Unavailability of COVID-19 testing linked to greater intentions to engage in risky behavior

Study identifies SARS-CoV-2 variants with potential to escape the immune system's T cell response

ISU surveillance efforts uncover invasive mosquito species in three Iowa counties

KHN’s ‘What the Health?’: FDA takes center stage

Spillover of SARS-CoV-2 Omicron variant infection in white-tailed deer in New York

Study reports accumulation of SARS-CoV-2 RNA in sewer biofilms

Study: Almost a third of older adults infected with covid-19 develop new conditions

Scientists identify multi-kinase inhibitors that can effectively block SARS-CoV-2-mediated cytokine release

Protective efficacy of BNT162b2 and Ad26.COV2.S against SARS-CoV-2 Omicron challenge in nonhuman primates

Comparison of SARS-CoV-2 test performance by sample type and modality in close contacts of SARS-CoV-2 cases

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

Regular surveillance testing of a community can prevent Covid-19 outbreaks

Persistent Ebola virus can hide in the brain and re-emerge to cause fatal disease

Super-resolution imaging of the human coronavirus genome during infection

The serious risks COVID-19 may pose during pregnancy

How SARS-CoV-2 infection progresses throughout the respiratory system

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

A new way of characterising biomolecules eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in